Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tianeptine vs Pregabalin for Prevention of Post-Mastectomy Pain Syndrome
NCT05935059Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tianeptine in Post-mastectomy pain syndrome (PMPS) (2 arms), sponsored by National Cancer Institute. Primary endpoint: Percentage of patients who developed Post Mastectomy Pain Syndrome at 6 months. Started Jun 2023; status: completed.
02
Drugs
tianeptine
03
Conditions
Post-mastectomy pain syndrome (PMPS)
Beyond the preview
Go deeper on NCT05935059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05935059.